| 1. |
Huang L, Mao Y, Yang J, et al. Mutation screening of the USH2A gene in retinitis pigmentosa and USHER patients in a Han Chinese population[J]. Eye (Lond), 2018, 32(10): 1608-1614. DOI: 10.1038/s41433-018-0130-3.
|
| 2. |
Vaché C, Besnard T, le Berre P, et al. Usher syndrome type 2 caused by activation of an USH2A pseudoexon: implications for diagnosis and therapy[J]. Hum Mutat, 2012, 33(1): 104-108. DOI: 10.1002/humu.21634.
|
| 3. |
Liu S, Bi JG, Hu Y, et al. Targeted next generation sequencing identified novel loss-of-function mutations in MERTK gene in Chinese patients with retinitis pigmentosa[J/OL]. Mol Genet Genomic Med, 2019, 7(4): 00577[2019-02-20]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465654/. DOI: 10.1002/mgg3.577.
|
| 4. |
Liquori A, Vaché C, Baux D, et al. Whole USH2A gene sequencing identifies several new deep intronic mutations[J]. Hum Mutat, 2016, 37(2): 184-193. DOI: 10.1002/humu.22926.
|
| 5. |
van Wijk E, Pennings RJ, te Brinke H, et al. Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type Ⅱ[J]. Am J Hum Genet, 2004, 74(4): 738-744. DOI: 10.1086/383096.
|
| 6. |
Wang Q, Zhu H, Xiao Z, et al. Expression of epidermal growth factor receptor is an independent prognostic factor for esophageal squamous cell carcinoma[J]. World J Surg Oncol, 2013, 11: 278. DOI: 10.1186/1477-7819-11-278.
|
| 7. |
GeneReviews?[M]. Seattle (WA): University of Washington, Seattle, 1993.
|
| 8. |
Kremer H, van Wijk E, Märker T, et al. Usher syndrome: molecular links of pathogenesis, proteins and pathways[J]. Hum Mol Genet, 2006, 15(2): 262-270. DOI: 10.1093/hmg/ddl205.
|
| 9. |
Xu W, Dai H, Lu T, et al. Seven novel mutations in the long isoform of the USH2A gene in Chinese families with nonsyndromic retinitis pigmentosa and Usher syndrome type Ⅱ[J]. Mol Vis, 2011, 17: 1537-1552.
|
| 10. |
Yan D, Liu XZ. Genetics and pathological mechanisms of Usher syndrome[J]. J Hum Genet, 2010, 55(6): 327-335. DOI: 10.1038/jhg.2010.29.
|
| 11. |
Reiners J, Nagel-Wolfrum K, Jürgens K, et al. Molecular basis of human Usher syndrome: deciphering the meshes of the Usher protein network provides insights into the pathomechanisms of the Usher disease[J]. Exp Eye Res, 2006, 83(1): 97-119. DOI: 10.1016/j.exer.2005.11.010.
|
| 12. |
Aller E, Jaijo T, Beneyto M, et al. Identification of 14 novel mutations in the long isoform of USH2A in Spanish patients with Usher syndrome type Ⅱ[J]. J Med Genet, 2006, 43(11): 55. DOI: 10.1136/jmg.2006.041764.
|
| 13. |
Ng TK, Tang W, Cao Y, et al. Whole exome sequencing identifies novel USH2A mutations and confirms Usher syndrome 2 diagnosis in Chinese retinitis pigmentosa patients[J]. Sci Rep, 2019, 9(1): 5628. DOI: 10.1038/s41598-019-42105-0.
|
| 14. |
McGee TL, Seyedahmadi BJ, Sweeney MO, et al. Novel mutations in the long isoform of the USH2A gene in patients with Usher syndrome type Ⅱ or non-syndromic retinitis pigmentosa[J]. J Med Genet, 2010, 47(7): 499-506. DOI: 10.1136/jmg.2009.075143.
|
| 15. |
王瑛, 黃輝, 樊寧, 等. 目標區域捕獲技術鑒定一RP家系USH2A基因的新復合雜合突變[J]. 中華實驗眼科雜志, 2016, 34(3): 244-247. DOI: 10.3760/cma.j.issn.2095-0160.2016.03.011.Wang Y, Huang H, Fan N, et al. Identification of novel compound heterozygous mutations of USH2A gene in a RP pedigree by targeted-capture next generation sequencing[J]. Chin J Exp Ophthalmol, 2016, 34(3): 244-247. DOI: 10.3760/cma.j.issn.2095-0160.2016.03.011.
|
| 16. |
Méndez-Vidal C, González-Del Pozo M, Vela-Boza A, et al. Whole-exome sequencing identifies novel compound heterozygous mutations in USH2A in Spanish patients with autosomal recessive retinitis pigmentosa[J]. Mol Vis, 2013, 19: 2187-2195.
|